Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides medical and healthcare services. Located in Saburtalo district.
Subsidiary of Sakartvelos Sameditsino Holding (100.0%)
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 65.0% | 64.4% | 63.7% | 56.6% | 28.7% | 43.8% | 32.3% | 66.4% |
| EBITDA Margin | 51.2% | -1.3% | -10.6% | -16.7% | -21.5% | -73.0% | -273.9% | -198.5% |
| EBITDAR | 8,583 | -222 | -1,540 | -2,619 | -12,126 | -18,600 | -35,676 | -7,078 |
| EBITDAR Margin | 51.2% | -1.3% | -10.6% | -16.7% | -21.5% | -73.0% | -273.9% | -198.5% |
| EBIT Margin | 48.1% | -3.6% | -12.6% | -22.4% | -26.3% | -90.5% | -308.1% | -272.8% |
| Net Profit Margin | -6.0% | -4.9% | -4.8% | 68.6% | 54.3% | -1.9% | -238.2% | 82.8% |
| Operating Expense % of Sales | 13.8% | 65.8% | 74.2% | 73.3% | 50.2% | 116.7% | 306.2% | 264.9% |
| Returns | ||||||||
| Return on Assets (ROA) | -14.4% | -11.5% | -12.5% | 26.8% | 36.3% | -0.6% | -60.8% | 10.6% |
| Return on Equity (ROE) | N/A | N/A | N/A | 114.2% | 75.9% | -1.3% | -579.0% | 20.2% |
| ROIC [EBIT / Invested Capital] | N/A | N/A | N/A | N/A | -150.6% | -174.3% | N/A | -73.6% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 5.9% | 7.1% | 8.0% | 0.0% | 0.0% | 2.5% | 10.9% | 2.8% |
| Debt-to-Equity | -0.23x | -0.19x | -0.16x | 0.00x | 0.00x | 0.05x | 1.04x | 0.05x |
| Debt-to-EBITDA | 0.05x | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity-to-Assets | -25.7% | -36.4% | -50.5% | 23.4% | 47.9% | 46.3% | 10.5% | 52.4% |
| Net Debt | 286 | 293 | 437 | -19,031 | -30,539 | -24,147 | -15,634 | -1,401 |
| Cash & Equivalents | 128 | 219 | 11 | 19,044 | 30,552 | 26,160 | 21,217 | 2,192 |
| Total Debt | 414 | 511 | 448 | 13 | 13 | 2,013 | 5,583 | 791 |
| Liquidity & working capital | ||||||||
| Current Ratio | 0.77x | 0.00x | 0.44x | 2.31x | 2.70x | 2.28x | 1.17x | 0.66x |
| Quick Ratio | 0.77x | -0.22x | 0.23x | 2.04x | 2.20x | 1.66x | 0.89x | 0.20x |
| Cash Ratio | 0.02x | 0.02x | 0.00x | 1.63x | 1.57x | 1.38x | 0.85x | 0.17x |
| Total Current Assets | 6,026 | 6 | 3,721 | 27,028 | 52,613 | 43,159 | 29,078 | 8,751 |
| Total Current Liabilities | 7,789 | 9,846 | 8,443 | 11,717 | 19,493 | 18,949 | 24,941 | 13,278 |
| Inventory | N/A | 2,208 | 1,764 | 3,078 | 9,662 | 11,779 | 6,762 | 6,037 |
| Trade Receivables | 3,564 | 3,580 | 1,947 | 4,906 | 12,399 | 5,220 | 1,099 | 522 |
| Trade Payables | 4,535 | 4,975 | 3,826 | 9,256 | 16,969 | 12,745 | 13,271 | 11,972 |
| Net Working Capital | -1,763 | -9,840 | -4,722 | 15,311 | 33,120 | 24,210 | 4,137 | -4,527 |
| Net Working Capital % of Revenue | -10.5% | -58.4% | -32.4% | 97.4% | 58.7% | 95.0% | 31.8% | -127.0% |
| Trade Working Capital | -971 | 813 | -116 | -1,272 | 5,092 | 4,254 | -5,410 | -5,413 |
| Trade Working Capital % of Revenue | -5.8% | 4.8% | -0.8% | -8.1% | 9.0% | 16.7% | -41.5% | -151.8% |
| Change in Trade Working Capital | N/A | 1,784 | -929 | -1,156 | 6,364 | -838 | -9,664 | -3 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | N/A | 2.71x | 3.01x | 2.22x | 4.16x | 1.22x | 1.30x | 0.20x |
| Days Inventory Outstanding (DIO) | N/A | 134.5 | 121.4 | 164.8 | 87.7 | 299.9 | 279.8 | 1839.3 |
| Receivables Turnover | 4.70x | 4.71x | 7.49x | 3.20x | 4.55x | 4.88x | 11.85x | 6.83x |
| Days Sales Outstanding (DSO) | 77.6 | 77.6 | 48.7 | 113.9 | 80.2 | 74.7 | 30.8 | 53.4 |
| Payables Turnover | 1.29x | 1.20x | 1.39x | 0.74x | 2.37x | 1.12x | 0.66x | 0.10x |
| Days Payable Outstanding (DPO) | 282.4 | 303.1 | 263.4 | 495.4 | 154.0 | 324.4 | 549.1 | 3647.6 |
| Cash Conversion Cycle | -204.8 days | -91.0 days | -93.3 days | -216.8 days | 13.9 days | 50.1 days | -238.5 days | -1754.8 days |
| Asset Turnover | 2.40x | 2.33x | 2.60x | 0.39x | 0.67x | 0.32x | 0.26x | 0.13x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 1,782 | 222 | 443 | 583 | 5,270 | -6,844 | -6,757 | -11,330 |
| Free Cash Flow (OCF − Capex proxy) | 1,782 | -6 | -148 | -1,429 | -2,722 | -5,330 | -6,218 | -10,488 |
| Cash Conversion (OCF / EBITDA) | 20.8% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout Ratio | N/A | N/A | N/A | 0.0% | 0.0% | N/A | N/A | 0.0% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →